Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study

A C K Larstorp; P M Okin; R B Devereux; M H Olsen; H. Ibsen; B Dahlöf; Eigil Kjeldsen; Kristian Wachtell

doi:10.1038/jhh.2010.52

Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study

A C K Larstorp, P M Okin, R B Devereux, M H Olsen, H. Ibsen, B Dahlöf, Eigil Kjeldsen, Kristian Wachtell

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

The predictive value of changes in the severity of electrocardiographic left ventricular hypertrophy (ECG-LVH) during antihypertensive therapy remains unclear in isolated systolic hypertension (ISH). In a Losartan Intervention For Endpoint reduction in hypertension substudy, we included 1320 patients aged 54-83 years with systolic blood pressure (BP) of 160-200 mm Hg, diastolic BP

Original language	English
Journal	Journal of Human Hypertension
Volume	25
Issue number	3
Pages (from-to)	178-85
Number of pages	8
ISSN	0950-9240
DOIs	https://doi.org/10.1038/jhh.2010.52
Publication status	Published - 2011

Keywords

Aged
Aged, 80 and over
Antihypertensive Agents
Atenolol
Electrocardiography
Female
Follow-Up Studies
Humans
Hypertension
Hypertrophy, Left Ventricular
Losartan
Male
Middle Aged
Myocardial Infarction
Prospective Studies
Randomized Controlled Trials as Topic
Risk
Severity of Illness Index
Smoking
Stroke
Treatment Outcome

Documents & Links

10.1038/jhh.2010.52

Cite this

@article{0450f3a4e8b148e5bf866c77ecd2bfc4,

title = "Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study",

abstract = "The predictive value of changes in the severity of electrocardiographic left ventricular hypertrophy (ECG-LVH) during antihypertensive therapy remains unclear in isolated systolic hypertension (ISH). In a Losartan Intervention For Endpoint reduction in hypertension substudy, we included 1320 patients aged 54-83 years with systolic blood pressure (BP) of 160-200 mm Hg, diastolic BP ",

keywords = "Aged, Aged, 80 and over, Antihypertensive Agents, Atenolol, Electrocardiography, Female, Follow-Up Studies, Humans, Hypertension, Hypertrophy, Left Ventricular, Losartan, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Randomized Controlled Trials as Topic, Risk, Severity of Illness Index, Smoking, Stroke, Treatment Outcome",

author = "Larstorp, {A C K} and Okin, {P M} and Devereux, {R B} and Olsen, {M H} and H. Ibsen and B Dahl{\"o}f and Eigil Kjeldsen and Kristian Wachtell",

year = "2011",

doi = "10.1038/jhh.2010.52",

language = "English",

volume = "25",

pages = "178--85",

journal = "Journal of Human Hypertension",

issn = "0950-9240",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study

AU - Larstorp, A C K

AU - Okin, P M

AU - Devereux, R B

AU - Olsen, M H

AU - Ibsen, H.

AU - Dahlöf, B

AU - Kjeldsen, Eigil

AU - Wachtell, Kristian

PY - 2011

Y1 - 2011

N2 - The predictive value of changes in the severity of electrocardiographic left ventricular hypertrophy (ECG-LVH) during antihypertensive therapy remains unclear in isolated systolic hypertension (ISH). In a Losartan Intervention For Endpoint reduction in hypertension substudy, we included 1320 patients aged 54-83 years with systolic blood pressure (BP) of 160-200 mm Hg, diastolic BP

AB - The predictive value of changes in the severity of electrocardiographic left ventricular hypertrophy (ECG-LVH) during antihypertensive therapy remains unclear in isolated systolic hypertension (ISH). In a Losartan Intervention For Endpoint reduction in hypertension substudy, we included 1320 patients aged 54-83 years with systolic blood pressure (BP) of 160-200 mm Hg, diastolic BP

KW - Aged

KW - Aged, 80 and over

KW - Antihypertensive Agents

KW - Atenolol

KW - Electrocardiography

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Hypertension

KW - Hypertrophy, Left Ventricular

KW - Losartan

KW - Male

KW - Middle Aged

KW - Myocardial Infarction

KW - Prospective Studies

KW - Randomized Controlled Trials as Topic

KW - Risk

KW - Severity of Illness Index

KW - Smoking

KW - Stroke

KW - Treatment Outcome

U2 - 10.1038/jhh.2010.52

DO - 10.1038/jhh.2010.52

M3 - Journal article

C2 - 20505749

SN - 0950-9240

VL - 25

SP - 178

EP - 185

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

IS - 3

ER -

Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study

Abstract

Keywords

Documents & Links

Fingerprint

Cite this